UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:WDR75-ATIC |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: WDR75-ATIC | FusionPDB ID: 99090 | FusionGDB2.0 ID: 99090 | Hgene | Tgene | Gene symbol | WDR75 | ATIC | Gene ID | 84128 | 471 |
Gene name | WD repeat domain 75 | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | |
Synonyms | NET16|UTP17 | AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH | |
Cytomap | 2q32.2 | 2q35 | |
Type of gene | protein-coding | protein-coding | |
Description | WD repeat-containing protein 75U3 small nucleolar RNA-associated protein 17 homologUTP17, small subunit (SSU) processome component, homolog | bifunctional purine biosynthesis protein PURH5-aminoimidazole-4-carboxamide-1-beta-D-ribonucleotide transformylase/inosinicaseAICAR formyltransferase/IMP cyclohydrolase bifunctional enzymeAICARFT/IMPCHASEepididymis secretory sperm binding protein Li 7 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | P31939 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000314761, | ENST00000236959, ENST00000435675, ENST00000540518, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 4 X 3 X 3=36 | 10 X 9 X 4=360 |
# samples | 4 | 10 | |
** MAII score | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(10/360*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: WDR75 [Title/Abstract] AND ATIC [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | WDR75(190320170)-ATIC(216200758), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | WDR75-ATIC seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. WDR75-ATIC seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. WDR75-ATIC seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. WDR75-ATIC seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | ERR315399 | WDR75 | chr2 | 190320170 | + | ATIC | chr2 | 216200758 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000314761 | WDR75 | chr2 | 190320170 | + | ENST00000236959 | ATIC | chr2 | 216200758 | + | 1437 | 558 | 60 | 1328 | 422 |
ENST00000314761 | WDR75 | chr2 | 190320170 | + | ENST00000540518 | ATIC | chr2 | 216200758 | + | 1437 | 558 | 60 | 1328 | 422 |
ENST00000314761 | WDR75 | chr2 | 190320170 | + | ENST00000435675 | ATIC | chr2 | 216200758 | + | 1437 | 558 | 60 | 1328 | 422 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000314761 | ENST00000236959 | WDR75 | chr2 | 190320170 | + | ATIC | chr2 | 216200758 | + | 0.000536299 | 0.99946374 |
ENST00000314761 | ENST00000540518 | WDR75 | chr2 | 190320170 | + | ATIC | chr2 | 216200758 | + | 0.000536299 | 0.99946374 |
ENST00000314761 | ENST00000435675 | WDR75 | chr2 | 190320170 | + | ATIC | chr2 | 216200758 | + | 0.000536299 | 0.99946374 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >99090_99090_1_WDR75-ATIC_WDR75_chr2_190320170_ENST00000314761_ATIC_chr2_216200758_ENST00000236959_length(amino acids)=422AA_BP=166 MVEEENIRVVRCGGSELNFRRAVFSADSKYIFCVSGDFVKVYSTVTEECVHILHGHRNLVTGIQLNPNNHLQLYSCSLDGTIKLWDYIDG ILIKTFIVGCKLHALFTLAQAEDSVFVIVNKEKPDIFQLVSVKLPKSSSQEVEAKELSFVLDYINQSPKCIAFGNEVSDGIIAPGYEEEA LTILSKKKNGNYCVLQMDQSYKPDENEVRTLFGLHLSQKRNNGVVDKSLFSNVVTKNKDLPESALRDLIVATIAVKYTQSNSVCYAKNGQ VIGIGAGQQSRIHCTRLAGDKANYWWLRHHPQVLSMKFKTGVKRAEISNAIDQYVTGTIGEDEDLIKWKALFEEVPELLTEAEKKEWVEK -------------------------------------------------------------- >99090_99090_2_WDR75-ATIC_WDR75_chr2_190320170_ENST00000314761_ATIC_chr2_216200758_ENST00000435675_length(amino acids)=422AA_BP=166 MVEEENIRVVRCGGSELNFRRAVFSADSKYIFCVSGDFVKVYSTVTEECVHILHGHRNLVTGIQLNPNNHLQLYSCSLDGTIKLWDYIDG ILIKTFIVGCKLHALFTLAQAEDSVFVIVNKEKPDIFQLVSVKLPKSSSQEVEAKELSFVLDYINQSPKCIAFGNEVSDGIIAPGYEEEA LTILSKKKNGNYCVLQMDQSYKPDENEVRTLFGLHLSQKRNNGVVDKSLFSNVVTKNKDLPESALRDLIVATIAVKYTQSNSVCYAKNGQ VIGIGAGQQSRIHCTRLAGDKANYWWLRHHPQVLSMKFKTGVKRAEISNAIDQYVTGTIGEDEDLIKWKALFEEVPELLTEAEKKEWVEK -------------------------------------------------------------- >99090_99090_3_WDR75-ATIC_WDR75_chr2_190320170_ENST00000314761_ATIC_chr2_216200758_ENST00000540518_length(amino acids)=422AA_BP=166 MVEEENIRVVRCGGSELNFRRAVFSADSKYIFCVSGDFVKVYSTVTEECVHILHGHRNLVTGIQLNPNNHLQLYSCSLDGTIKLWDYIDG ILIKTFIVGCKLHALFTLAQAEDSVFVIVNKEKPDIFQLVSVKLPKSSSQEVEAKELSFVLDYINQSPKCIAFGNEVSDGIIAPGYEEEA LTILSKKKNGNYCVLQMDQSYKPDENEVRTLFGLHLSQKRNNGVVDKSLFSNVVTKNKDLPESALRDLIVATIAVKYTQSNSVCYAKNGQ VIGIGAGQQSRIHCTRLAGDKANYWWLRHHPQVLSMKFKTGVKRAEISNAIDQYVTGTIGEDEDLIKWKALFEEVPELLTEAEKKEWVEK -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:190320170/chr2:216200758) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | ATIC |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Bifunctional enzyme that catalyzes the last two steps of purine biosynthesis (PubMed:11948179, PubMed:14756554). Acts as a transformylase that incorporates a formyl group to the AMP analog AICAR (5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide) to produce the intermediate formyl-AICAR (FAICAR) (PubMed:9378707, PubMed:11948179, PubMed:10985775). Can use both 10-formyldihydrofolate and 10-formyltetrahydrofolate as the formyl donor in this reaction (PubMed:10985775). Also catalyzes the cyclization of FAICAR to IMP (PubMed:11948179, PubMed:14756554). Is able to convert thio-AICAR to 6-mercaptopurine ribonucleotide, an inhibitor of purine biosynthesis used in the treatment of human leukemias (PubMed:10985775). Promotes insulin receptor/INSR autophosphorylation and is involved in INSR internalization (PubMed:25687571). {ECO:0000269|PubMed:10985775, ECO:0000269|PubMed:11948179, ECO:0000269|PubMed:14756554, ECO:0000269|PubMed:25687571, ECO:0000269|PubMed:9378707}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 47_86 | 166.0 | 831.0 | Repeat | Note=WD 2 |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 4_43 | 166.0 | 831.0 | Repeat | Note=WD 1 |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 90_131 | 166.0 | 831.0 | Repeat | Note=WD 3 |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000236959 | 9 | 16 | 565_566 | 336.0 | 593.0 | Region | 10-formyltetrahydrofolate binding | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000435675 | 8 | 15 | 565_566 | 335.0 | 592.0 | Region | 10-formyltetrahydrofolate binding |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 145_184 | 166.0 | 831.0 | Repeat | Note=WD 4 |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 193_231 | 166.0 | 831.0 | Repeat | Note=WD 5 |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 237_276 | 166.0 | 831.0 | Repeat | Note=WD 6 |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 279_318 | 166.0 | 831.0 | Repeat | Note=WD 7 |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 324_362 | 166.0 | 831.0 | Repeat | Note=WD 8 |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 376_423 | 166.0 | 831.0 | Repeat | Note=WD 9 |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 430_474 | 166.0 | 831.0 | Repeat | Note=WD 10 |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 487_525 | 166.0 | 831.0 | Repeat | Note=WD 11 |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 529_569 | 166.0 | 831.0 | Repeat | Note=WD 12 |
Hgene | WDR75 | chr2:190320170 | chr2:216200758 | ENST00000314761 | + | 5 | 21 | 574_611 | 166.0 | 831.0 | Repeat | Note=WD 13 |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000236959 | 9 | 16 | 2_146 | 336.0 | 593.0 | Domain | MGS-like | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000435675 | 8 | 15 | 2_146 | 335.0 | 592.0 | Domain | MGS-like | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000236959 | 9 | 16 | 101_102 | 336.0 | 593.0 | Nucleotide binding | IMP | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000236959 | 9 | 16 | 125_126 | 336.0 | 593.0 | Nucleotide binding | IMP | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000236959 | 9 | 16 | 12_14 | 336.0 | 593.0 | Nucleotide binding | IMP | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000236959 | 9 | 16 | 34_37 | 336.0 | 593.0 | Nucleotide binding | IMP | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000236959 | 9 | 16 | 64_67 | 336.0 | 593.0 | Nucleotide binding | IMP | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000435675 | 8 | 15 | 101_102 | 335.0 | 592.0 | Nucleotide binding | IMP | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000435675 | 8 | 15 | 125_126 | 335.0 | 592.0 | Nucleotide binding | IMP | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000435675 | 8 | 15 | 12_14 | 335.0 | 592.0 | Nucleotide binding | IMP | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000435675 | 8 | 15 | 34_37 | 335.0 | 592.0 | Nucleotide binding | IMP | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000435675 | 8 | 15 | 64_67 | 335.0 | 592.0 | Nucleotide binding | IMP | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000236959 | 9 | 16 | 199_592 | 336.0 | 593.0 | Region | AICAR formyltransferase | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000236959 | 9 | 16 | 207_208 | 336.0 | 593.0 | Region | AICAR binding | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000236959 | 9 | 16 | 2_198 | 336.0 | 593.0 | Region | IMP cyclohydrolase | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000435675 | 8 | 15 | 199_592 | 335.0 | 592.0 | Region | AICAR formyltransferase | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000435675 | 8 | 15 | 207_208 | 335.0 | 592.0 | Region | AICAR binding | |
Tgene | ATIC | chr2:190320170 | chr2:216200758 | ENST00000435675 | 8 | 15 | 2_198 | 335.0 | 592.0 | Region | IMP cyclohydrolase |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
ATIC | PSTPIP1, IKBKE, ELF3, JAK1, RADIL, STOM, HNRNPDL, SNRPA, NDUFAF1, CMBL, NME2, EGFR, SIRT7, ISG15, CDK2, CLNS1A, TYMS, OXCT1, RBBP6, CRK, TARDBP, SUMO2, TXN, ASB6, AHCY, CAPN2, CTH, FH, GMDS, MCTS1, STK26, MYO1E, OGFOD1, PAPSS1, PTMA, TATDN1, UBA1, IPO5, ISOC1, MSN, NAE1, NSFL1C, PAFAH1B1, PROSC, YWHAE, CUL7, INSR, ALDH16A1, ACOT13, ADSL, C6orf211, CTBP1, DERA, DNM1L, GLO1, HSPB1, KCNAB1, KCNAB2, PAICS, PGM1, PLIN3, SHMT1, SPR, EEF2, ELAC2, GART, RTN4, TRNT1, NTRK1, U2AF2, CDH1, MTNR1A, SERPINB5, CTNNB1, UBE2M, RNF123, AGR2, MYC, PRNP, BCAT1, DIABLO, ECH1, YWHAG, CAPNS1, LDHA, BIRC3, LMBR1L, TEX101, PINK1, LINC01554, CAV1, PRKCE, SH3GL3, SHOC2, EMC2, CIT, PRC1, IFI16, PYHIN1, FASN, SREBF2, NDN, BRD4, DDX58, OGT, ATG7, NAA40, KAT6A, CTSL, IFITM1, IFITM3, CLEC4D, CLEC4E, CCNF, |
![]() |
Gene | STRING network |
WDR75 | |
ATIC | ![]() |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to WDR75-ATIC |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to WDR75-ATIC |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | ATIC | C0001787 | Osteoporosis, Age-Related | 1 | CTD_human |
Tgene | ATIC | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Tgene | ATIC | C0013221 | Drug toxicity | 1 | CTD_human |
Tgene | ATIC | C0029456 | Osteoporosis | 1 | CTD_human |
Tgene | ATIC | C0029459 | Osteoporosis, Senile | 1 | CTD_human |
Tgene | ATIC | C0041755 | Adverse reaction to drug | 1 | CTD_human |
Tgene | ATIC | C0155003 | Blindness, Transient | 1 | CTD_human |
Tgene | ATIC | C0221473 | Blindness, Hysterical | 1 | CTD_human |
Tgene | ATIC | C0271215 | Blindness, Legal | 1 | CTD_human |
Tgene | ATIC | C0339730 | Blindness, Acquired | 1 | CTD_human |
Tgene | ATIC | C0376288 | Amaurosis | 1 | CTD_human |
Tgene | ATIC | C0456909 | Blindness | 1 | CTD_human |
Tgene | ATIC | C0750958 | Blindness, Monocular | 1 | CTD_human |
Tgene | ATIC | C0751406 | Post-Traumatic Osteoporosis | 1 | CTD_human |
Tgene | ATIC | C1837530 | AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | ATIC | C1879328 | Blindness both eyes NOS (disorder) | 1 | CTD_human |
Tgene | ATIC | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND |